345 related articles for article (PubMed ID: 28797893)
1. Genetic association of telomere length with hepatocellular carcinoma risk: A Mendelian randomization analysis.
Cheng Y; Yu C; Huang M; Du F; Song C; Ma Z; Zhai X; Yang Y; Liu J; Bei JX; Jia W; Jin G; Li S; Zhou W; Liu J; Dai J; Hu Z
Cancer Epidemiol; 2017 Oct; 50(Pt A):39-45. PubMed ID: 28797893
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte telomere length-related rs621559 and rs398652 genetic variants influence risk of HBV-related hepatocellular carcinoma.
Pan W; Cheng G; Xing H; Shi J; Lu C; Wei J; Li L; Zhou C; Yuan Q; Zhou L; Yang M
PLoS One; 2014; 9(11):e110863. PubMed ID: 25365256
[TBL] [Abstract][Full Text] [Related]
3. Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.
Wan S; Hann HW; Ye Z; Hann RS; Lai Y; Wang C; Li L; Myers RE; Li B; Xing J; Yang H
Carcinogenesis; 2017 Apr; 38(4):439-446. PubMed ID: 28334112
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers.
Kao WY; Yang SH; Liu WJ; Yeh MY; Lin CL; Liu CJ; Huang CJ; Lin SM; Lee SD; Chen PJ; Yu MW
Mol Carcinog; 2017 Feb; 56(2):425-435. PubMed ID: 27254796
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B infection is causally associated with extrahepatic cancers: A Mendelian randomization study.
Kamiza AB; Fatumo S; Singini MG; Yeh CC; Chikowore T
EBioMedicine; 2022 May; 79():104003. PubMed ID: 35447390
[TBL] [Abstract][Full Text] [Related]
6. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
[TBL] [Abstract][Full Text] [Related]
7. Longer leukocyte telomere length predicts increased risk of hepatitis B virus-related hepatocellular carcinoma: a case-control analysis.
Liu J; Yang Y; Zhang H; Zhao S; Liu H; Ge N; Yang H; Xing JL; Chen Z
Cancer; 2011 Sep; 117(18):4247-56. PubMed ID: 21387275
[TBL] [Abstract][Full Text] [Related]
8. Association between telomere length and hepatocellular carcinoma risk: A Mendelian randomization study.
Yang C; Wu X; Chen S; Xiang B
Cancer Med; 2023 Apr; 12(8):9937-9944. PubMed ID: 36880214
[TBL] [Abstract][Full Text] [Related]
9. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
[TBL] [Abstract][Full Text] [Related]
10. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
11. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus genotypes, expression quantitative trait loci for ZNRD1-AS1 and their interactions in hepatocellular carcinoma.
Liu Z; Song C; Wen J; Xu L; Liu Y; Zhu J; Zhu L; Hu Z; Ma H; Liu L
Oncotarget; 2016 Jul; 7(28):44076-44083. PubMed ID: 27286450
[TBL] [Abstract][Full Text] [Related]
13. The characteristic changes in hepatitis B virus x region for hepatocellular carcinoma: a comprehensive analysis based on global data.
Li W; Goto K; Matsubara Y; Ito S; Muroyama R; Li Q; Kato N
PLoS One; 2015; 10(5):e0125555. PubMed ID: 25942596
[TBL] [Abstract][Full Text] [Related]
14. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
15. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
16. Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence.
Feng W; Yu D; Li B; Luo OY; Xu T; Cao Y; Ding Y
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28108675
[TBL] [Abstract][Full Text] [Related]
17. Potentially functional genetic variants in microRNA processing genes and risk of HBV-related hepatocellular carcinoma.
Liu L; An J; Liu J; Wen J; Zhai X; Liu Y; Pan S; Jiang J; Wen Y; Liu Z; Zhang Y; Chen J; Xing J; Ji G; Shen H; Hu Z; Fan Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E148-54. PubMed ID: 23868705
[TBL] [Abstract][Full Text] [Related]
18. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
19. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
[TBL] [Abstract][Full Text] [Related]
20. Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers.
Mohamadkhani A; Pourasgari M; Poustchi H
Asian Pac J Cancer Prev; 2018 Mar; 19(3):585-590. PubMed ID: 29579787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
